Program Information
Cranial Multi-Metastases SRS Commissioning with M120 MLC
S Lim*, L Kuo , X Li , A Ballangrud , T LoSasso , Memorial Sloan-Kettering Cancer Center, New York, NY
Presentations
SU-I-GPD-T-593 (Sunday, July 30, 2017) 3:00 PM - 6:00 PM Room: Exhibit Hall
Purpose: To commission a custom VMAT multi-lesions and a DCA single lesion 6MV AAA Eclipse beam models for cranial SRS treatments on a Varian TrueBeam with M120 multi-leaf collimator (MLC)
Methods: Seven clinical VMAT plans, with 1-6 targets each, and three single target DCA plans are created using the custom models with (1.75,0.75) and (0,0) focal spots respectively. The respective targets of the VMAT and DCA plans range are 0.7-4.1cc, and 0.1-10.9cc. All VMAT plans are measured with EBT3 films in a 30x30x10cm solid water phantom on treatment couch with rotating gantry on a Varian TrueBeam with M120 MLC. Exposed films are compared with the calculation using average dose-difference,
Results: The respective
Conclusion: The custom models are capable to generate acceptable dosimetry from 0.1 to 10.9cc targets with the combination of VMAT and DCA techniques. Multiple targets larger than 0.7cc should be grouped and treated with a singe isocenter VMAT plan. A separate DCA plan should be considered for targets between 0.1 and 0.7cc.
Contact Email: